NCODA Logo

SAN DIEGOFeb. 4, 2021 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) and NCODA (National Community Oncology Dispensing Association, Inc.), a premier educational platform for community and academic oncology practices nationwide, are launching a collaboration to positively impact the quality of life for female patients living with, fighting and recovering from cancer by raising awareness about the importance and availability of a new non-hormonal birth control method, Phexxi® (lactic acid, citric acid and potassium bitartrate).

Evofem and NCODA will work together to develop and share resources and educational information for the medically-integrated oncology pharmacy team to help support their female cancer patients in deciding which contraceptive option best meets each woman’s unique, individual needs. The collaboration kicks off today – World Cancer Day.

Read More HERE